1,4-Dimethyl-3-phenyl-pyrazol | 26429-79-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1,4-Dimethyl-3-phenyl-pyrazol
• 英文别名: 1,4-dimethyl-3-phenyl-1H-pyrazole；1,4-dimethyl-3-phenyl-pyrazole；1,4-Dimethyl-3-phenylpyrazole
• CAS: 26429-79-8
• 化学式: C₁₁H₁₂N₂
• 分子量: 172.23
• InChiKey: VPAHFIIXEOFCFD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same
  申请人：Rheinheimer Joachim

  公开号：US20100304966A1

  公开（公告）日：2010-12-02

  Compounds of the formula I in which the substituents have the meaning given in the description, processes for preparing these compounds, compositions comprising them and their use for controlling harmful fungi.

  该式化合物I的取代基在描述中给出其含义，制备这些化合物的方法，包含它们的组合物以及它们用于控制有害真菌的用途。
• IAP BINDING COMPOUNDS
  申请人：Lundorf Mikkel Dybro

  公开号：US20110230419A1

  公开（公告）日：2011-09-22

  The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, solvates or prodrugs thereof, that bind to Inhibitor of Apoptosis Proteins (IAPs). The compounds of the invention may be used as diagnostic and therapeutic agents in the treatment of proliferative diseases, such as cancer, for promoting apoptosis in proliferating cells, and for sensitizing cells to inducers of apoptosis. The present invention furthermore provides a polymeric compound of formulas (VI) or (VII), comprising either at least two monomeric units of compounds of formula (I), or at least one monomeric unit of a compound of formula (I) and an entity E. The present invention further relates to pharmaceutical compositions comprising said compounds of formulas (I), (VI), and (VII) and the use of said compounds in medicine.

  本发明涉及式(I)的化合物，或其药学上可接受的盐、溶剂化合物或前药，其与凋亡抑制蛋白（IAPs）结合。本发明的化合物可用作诊断和治疗增生性疾病，例如癌症，促进增殖细胞的凋亡，并使细胞对凋亡诱导剂敏感。本发明还提供式(VI)或(VII)的聚合物化合物，其中包括至少两个式(I)的单体单位，或至少一个式(I)的单体单位和一个实体E。本发明还涉及包含上述化合物的药物组合物，以及在医学中使用上述化合物的用途。
• INHIBITORS OF IAP
  申请人：Cohen Frederick

  公开号：US20120202750A1

  公开（公告）日：2012-08-09

  The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I: wherein X, Y, A, R 1 , R 2 , R 3 , R 4 , R 4 ′, R 5 , R 5 ′, R 6 and R 6 ′ are as described herein.

  该发明提供了新型IAP抑制剂，可用作治疗恶性肿瘤的治疗剂，其中化合物具有一般式I：其中X、Y、A、R1、R2、R3、R4、R4'、R5、R5'、R6和R6'如本文所述。
• MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
  申请人：Constellation Pharmaceuticals, Inc.

  公开号：US20150259351A1

  公开（公告）日：2015-09-17

  Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.

  本文提供了调节甲基修饰酶的代理、组合物和使用方法。
• DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
  申请人：Genfleet Therapeutics (Shanghai) Inc.

  公开号：EP4105216A1

  公开（公告）日：2022-12-21

  Provided are a dihydronaphthyridinone compound as shown in formula (I), which compound has a selective inhibitory effect on RIPK1, and a pharmaceutically acceptable salt, a stereoisomer, a solvate or a prodrug thereof. In addition, provided are a pharmaceutical composition containing the compound, and the use thereof in the preparation of a drug for treating RIPK1-related diseases or conditions.

  提供了一种二氢萘啉酮化合物，如式（I）所示，该化合物对RIPK1具有选择性抑制作用，以及其药学上可接受的盐、立体异构体、溶剂化物或前药。此外，还提供了含有该化合物的制药组合物，并将其用于制备治疗RIPK1相关疾病或症状的药物。